Cosmos Health projects $12.5M+ revenue from 2023 acquisitions; exchanges warrants at $1.45

Cosmos Health Inc.

Entered warrant exchange for 4,874,126 new shares at $1.45 (down from $2.75); AGP gets $215K fee.
FY 2024 incremental revenue from 2023 acquisitions (Cana, Bikas, ZipDoctor) projected at $12.5M+ vs FY 2022.
FY 2024 gross profit from these acquisitions expected at $3.1M+; EBITDA >$1.3M (margin >10.4%).
FY 2023 incremental revenue from acquisitions estimated at ~$4M (under 6 months contribution).
Acquisitions added $15.5M in assets and $1.7M bargain purchase gain; carry zero debt.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Cosmos Health Inc. entered into Warrant Exchange Agreement with one holder of certain Company’s warrants (effective 2023-12-28).

Action: entry
Counterparty: one holder of certain Company’s warrants
Effective: 2023-12-28

Exact text from the filing

On December 28, 2023, Cosmos Health Inc. (the “Company”) entered into a warrant exchange agreement (the “Warrant Exchange Agreement”) with one holder of certain Company’s warrants issued on July 21, 2023 and December 21, 2022 (the “Existing Warrants”), pursuant to which the holder will exchange the Existing Warrants for new warrants (the “New Warrants”) to purchase up to an aggregate 4,874,126 shares of Common Stock

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-009401

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.